Study of MDX2301 for healthy adults and those at higher risk for severe COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial tests an investigational drug called MDX2301 to see if it's safe in healthy adults and in adults who are at higher risk for severe COVID-19. Higher risk means you have conditions like asthma, diabetes, heart disease, or other listed health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 64 years old
- Be either in good health OR have one or more of the listed risk factors for severe COVID-19 (like asthma, diabetes, heart disease, etc.)
- Not have received a COVID-19 vaccine or any COVID-19 treatment before joining
- Not be pregnant, breastfeeding, or planning to become pregnant during the study
- Be willing to use effective birth control if of childbearing potential
- Be able to visit the clinic as scheduled and follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new drug (called B10-FC) to see if it's safe and how the body processes it. It is given once to healthy adults, and later to people with mild or moderate COVID-19 who are at higher risk of getting very sick.
This trial studies whether PF-07321332 (with ritonavir) helps children under 18 who have COVID-19 at home but are at high risk of severe illness. It looks at whether starting treatment early can reduce progression to worse disease.
This study tests a new antibody medicine for people with COVID-19 who are at high risk of getting very sick. If you qualify, you would receive the study drug or a placebo (inactive substance) to see if it helps you recover without needing to go to the hospital.
This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.
This trial tests a new drug called MTX-101 in healthy volunteers to see if it is safe and how the body processes it. It helps determine the right dose before testing in patients with certain conditions.
This early-stage study tests COVID-19 treatments in people who have recently developed symptoms and who test positive for the virus. It aims to find safer, more effective options for preventing worsening disease, especially in higher-risk groups.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.